Merck & Co. at SLAS2027

Jan 30 – Feb 3, 2027 San Diego, CA ~7.6k attendees Website

Merck & Co. brings 2 presentations to SLAS2027 in San Diego. Its talks cover automation and digitalization across drug product development, and acoustic ejection mass spectrometry for high-throughput solubility work.

OrganizationSLAS2027 Attendance
Merck & Co.
Rahway, NJ
Biopharma
Pharmaceutical company, known as MSD outside the US and Canada, developing medicines and vaccines.
Talk
Mon Feb 1
4–4:25pm
Part of Validating the Virtual: In Silico Technologies, Digital Twins, and AI Auditors
From Digital Thread to Self-Driving Lab: Automation and Digitalization Across Drug Product Process Development
Ballroom 6C
Software, data and AI
Talk
Tue Feb 2
4:30–4:55pm
Part of Emerging Assays and Screening Technology
Acoustic ejection mass spectrometry enabling green, ultra‑high‑throughput kinetic solubility analysis
Ballroom 6D
Assay development and screening

Explore the full SLAS2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Diego. Leave your work email and we’ll be in touch.

Privacy

Download the full SLAS2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Merck & Co.

Tell us what you sell and we’ll find the people at Merck & Co. most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Society for Laboratory Automation and Screening. Organization details are derived from SLAS’s published exhibitor list and event scheduler. Submit a correction